Related Experiment Video
Updated: Jul 4, 2025

04:46
The Quantification of Injectability by Mechanical Testing
Published on: May 13, 2020
7.9K
Complications of Injectables.
1Facial Plastic & Reconstructive Surgery, 707 West Eau Gallie Boulevard, Melbourne, FL 32935, USA.
Atlas of the Oral and Maxillofacial Surgery Clinics of North America
|February 2, 2024
Summary
Non-surgical cosmetic procedures like neuromodulators and dermal fillers are increasingly popular. Safe and effective use requires deep knowledge of facial anatomy and potential complications for optimal patient outcomes.
Area of Science:
- Aesthetic Medicine
- Dermatology
- Plastic Surgery
Background:
- The demand for non-surgical esthetic procedures, including neuromodulators and dermal fillers, has significantly increased.
- These treatments are integral to facial rejuvenation and volume restoration.
- Societal acceptance of esthetic enhancements has grown, driving market expansion.
Purpose of the Study:
- To highlight the critical role of anatomical knowledge in the safe application of neuromodulators and dermal fillers.
- To review potential complications associated with these popular non-surgical treatments.
- To emphasize the necessity of comprehensive training and complication management in aesthetic medicine.
Main Methods:
- Review of current literature on neuromodulators and dermal fillers.
- Analysis of common and rare complications associated with these procedures.
- Emphasis on the importance of practitioner training and anatomical understanding.
Main Results:
- Neuromodulators require precise anatomical knowledge to prevent complications like ptosis.
- Dermal fillers carry risks such as bruising, edema, and lumps, with permanent fillers posing higher risks.
- Vascular occlusion is a severe, albeit rare, complication of dermal filler injections.
Conclusions:
- Non-surgical esthetic procedures offer significant benefits with minimal downtime.
- Thorough understanding of facial anatomy, product composition, and potential complications is paramount for patient safety.
- Continuous training and effective management of adverse events are essential for practitioners in aesthetic medicine.
Related Concept Videos
Drug Delivery: Parenteral Route
532
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
532
Routes of Drug Administration: Parenteral
1.9K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
1.9K
Insulin Formulations: Types and Delivery
197
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
197
Parenteral Anesthetics: Overview
127
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
127
Drug Delivery: Miscellaneous Routes
343
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
343
Insulin: Dosing Regimen and Adverse Effects
174
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174

